Abstract
Pharmacophore modeling: advances, limitations, and current utility in drug discovery Xiaoyu Qing,1,* Xiao Yin Lee,2,* Joren De Raeymaeker,1 Jeremy RH Tame,3 Kam YJ Zhang,2 Marc De Maeyer,1 Arnout RD Voet1,2 1Laboratory for Biomolecular Modelling, Department of Chemistry, Katholieke Universiteit Leuven, Heverlee, Belgium; 2Structural Bioinformatics Team, Center for Life Science Technologies, RIKEN, Yokohama, Kanagawa, Japan; 3Drug Design Laboratory, Yokohama City University, Yokohama, Kanagawa, Japan *These authors contributed equally to this work Abstract: Pharmacophore modeling is a successful yet very diverse subfield of computer-aided drug design. The concept of the pharmacophore has been widely applied to the rational design of novel drugs. In this paper, we review the computational implementation of this concept and its common usage in the drug discovery process. Pharmacophores can be used to represent and identify molecules on a 2D or 3D level by schematically depicting the key elements of molecular recognition. The most common application of pharmacophores is virtual screening, and different strategies are possible depending on the prior knowledge. However, the pharmacophore concept is also useful for ADME-tox modeling, side effect, and off-target prediction as well as target identification. Furthermore, pharmacophores are often combined with molecular docking simulations to improve virtual screening. We conclude this review by summarizing the new areas where significant progress may be expected through the application of pharmacophore modeling; these include protein–protein interaction inhibitors and protein design. Keywords: ADME-tox, computer-aided drug design, pharmacophore fingerprint, protein design, virtual screening 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.